LDEBIO
Latest round
- Series B
Last raised
- May 2021
Total raised
- $7.1M
Investors
- 4
About LDEBIO
Based in Guangzhou, China and established in 2013, LDEBIO is a biotechnology company which focuses on research and development of in vitro diagnostics, medical reagents, medical devices, etc., Ltd. The company focuses on the "full immune" diagnostic system-a new generation of in vitro diagnostic technology, which enables more accurate diagnostic analysis of complex immune-mediated diseases. The company focuses on major immune-mediated diseases. In the future, the company will build a marketing team, increase marketing investment, develop innovative products for full immunodiagnosis, and improve reagent production capacity.
Who invested in LDEBIO
4 investors across 3 rounds
See all investors in LDEBIO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LDEBIO
Who invested in LDEBIO?
LDEBIO has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LDEBIO raised?
LDEBIO has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did LDEBIO last raise money?
LDEBIO's most recent round on record is a Series B, in May 2021.
What does LDEBIO do?
Based in Guangzhou, China and established in 2013, LDEBIO is a biotechnology company which focuses on research and development of in vitro diagnostics, medical reagents, medical devices, etc.
Where is LDEBIO headquartered?
LDEBIO is headquartered in Guangzhou, China.
Which VCs invest in companies like LDEBIO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at LDEBIO's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like LDEBIO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.